Literature DB >> 1393602

Resting and reactive astrocytes express adrenergic receptors in the adult rat brain.

J Sutin1, Y Shao.   

Abstract

Adrenergic receptor subtypes were localized in situ and in cells isolated from the trigeminal motor nucleus and several other brain regions. To study receptor expression in reactive astrocytes, motor neuron degeneration and a glial reaction were induced in the trigeminal motor nucleus by the injection of the toxic lectin Ricin communis into the trigeminal motor root. Autoradiography following incubation of tissue sections in the alpha 1-ligand 125IBE 2254 (HEAT) or the beta-ligand 125Iodocyanopindolol (ICYP) showed a decrease in alpha 1- and an increase in beta-adrenergic receptor binding in the region of neuronal degeneration and gliosis. Glial hypertrophy, rather than hyperplasia, appears to be mainly responsible for the increased beta-binding, since inhibition of mitosis with cytosine arabinofuranoside only partially blocked elevations of beta-adrenergic receptor binding and GFAP immunolabelling in reactive astrocytes. More direct evidence for the expression of adrenergic receptors in normal and reactive astrocytes was obtained by combined autoradiography and immunohistochemistry of cells dissociated from the cerebral cortex, striatum, cerebellum, and trigeminal motor nucleus of adult rats. More than 88% of GFAP-positive astrocytes showed varying densities of beta-adrenergic receptor binding. In each region, the beta 2-subtype was proportionally greater than the beta 1-subtype. Astrocytes also expressed a significant density of alpha 1-receptors. Trigeminal motor neurons did not show beta-receptor binding, but had a density of alpha 1-receptors tenfold greater than astrocytes. A model for the role of astrocytes in adrenergic receptor-mediated modulation of trigeminal motor neuron excitability is discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1393602     DOI: 10.1016/0361-9230(92)90057-5

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  8 in total

1.  Differential expression of small heat shock proteins in reactive astrocytes after focal ischemia: possible role of beta-adrenergic receptor.

Authors:  T Imura; S Shimohama; M Sato; H Nishikawa; K Madono; A Akaike; J Kimura
Journal:  J Neurosci       Date:  1999-11-15       Impact factor: 6.167

2.  Glia mechanisms in mood regulation: a novel model of mood disorders.

Authors:  Younglim Lee; Denise Gaskins; Amit Anand; Anantha Shekhar
Journal:  Psychopharmacology (Berl)       Date:  2007-01-16       Impact factor: 4.530

3.  Adrenergic receptors in Alzheimer's disease brain: selective increases in the cerebella of aggressive patients.

Authors:  A Russo-Neustadt; C W Cotman
Journal:  J Neurosci       Date:  1997-07-15       Impact factor: 6.167

4.  β2-adrenergic receptor and astrocyte glucose metabolism.

Authors:  Jun-hong Dong; Xin Chen; Min Cui; Xiao Yu; Qi Pang; Jin-peng Sun
Journal:  J Mol Neurosci       Date:  2012-03-08       Impact factor: 3.444

5.  Columnar activity regulates astrocytic beta-adrenergic receptor-like immunoreactivity in V1 of adult monkeys.

Authors:  C Aoki; M Lubin; S Fenstemaker
Journal:  Vis Neurosci       Date:  1994 Jan-Feb       Impact factor: 3.241

Review 6.  Noradrenergic dysfunction in Alzheimer's disease.

Authors:  Mary Gannon; Pulin Che; Yunjia Chen; Kai Jiao; Erik D Roberson; Qin Wang
Journal:  Front Neurosci       Date:  2015-06-17       Impact factor: 4.677

Review 7.  Astrocytic Pathological Calcium Homeostasis and Impaired Vesicle Trafficking in Neurodegeneration.

Authors:  Nina Vardjan; Alexej Verkhratsky; Robert Zorec
Journal:  Int J Mol Sci       Date:  2017-02-08       Impact factor: 5.923

8.  Blockade of beta adrenergic receptors protects the blood brain barrier and reduces systemic pathology caused by HIV-1 Nef protein.

Authors:  Jocelyn Rivera-Ortiz; Jessalyn Pla-Tenorio; Myrella L Cruz; Krystal Colon; Jaileene Perez-Morales; Julio A Rodriguez; Jorge Martinez-Sicari; Richard J Noel
Journal:  PLoS One       Date:  2021-11-16       Impact factor: 3.752

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.